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Renal collecting duct endothelin-1 is a critical regulator of the
epithelial sodium channel (ENaC) and blood pressure (BP). Recently,
we showed that mice lacking the circadian clock protein Per1 exhibited
dramatically lower BP compared to wild type mice. Since ET-1 reduces
Na+ retention and Per1 represses expression of ET-1 mRNA in the
kidney, we hypothesized that elevated renal ET-1 levels contribute to
the lower BP in Per1 KOmice. Examination of ET-1 peptide levels in the
inner medulla of Per1 KO and WT mice showed that Per1 KO mice
expressed higher levels of ET-1. ET-1 peptide levels varied with a
circadian pattern that correlated with dipping of BP in wild type mice.
To further investigate a role for Per1 in the regulation of the endothelin
axis, ET-1, ETAR and ETBR mRNA expression were measured in lung,
heart, liver and the renal innermedulla.Measurementswere performed
at noon and midnight, representing the peak of murine rest and active
phases, respectively. The effect of reduced Per1 expression on levels of
the endothelin axis and the circadian pattern of expression appeared to
be tissue speciﬁc. For example, in the renal inner medulla, ETAR and
ETBR exhibited peaks of expression in opposite circadian phases. In
contrast, lung expression of ET-1, ETAR and ETBR did not vary with a
circadian pattern, but ET-1 expression was dramatically decreased in
Per1 heterozygous mice. Heart and liver also showed distinctive
circadian expression of ET-1, ETAR and ETBR. These observations may
have important implications for our understanding of the best time of
day to deliver endothelin receptor antagonists.
doi:10.1016/j.lfs.2013.12.217
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Since a series of gene knockout studies in 1990s, the endothelin
system has emerged as a key determinant in embryonic development.
Wehave shown that the endothelin-1 (ET-1)/endothelin type-A receptor
(ETAR) pathway acts as a molecular switch that speciﬁes the ventral
identity of the pharyngeal arches to form the lower jaw and related
structures. Mice deﬁcient in ET-1/ETAR signaling also showed anomalies
in the great arteries. The preotic (cranial) and postotic (cardiac) neural
crest cells are responsible for these processes as a target cell population.
Recently, we found that the cranial neural crest from the preotic region,
rather than post-otic ‘cardiac’ neural crest cells, migrate into the heart
and differentiate into coronary artery smooth muscle cells in the
proximal region (Nat. Commun. 3: 1267, 2012). Ablation of the preotic
neural crest in chick embryos causes abnormalities in coronary septal
branch and oriﬁce formation. Appropriate migration and deployment of
neural crest cells and subsequent smooth muscle differentiation require
multicellular interactions involving ET-1/ETAR signaling possibly through
G12/13-mediated mechanisms, whereas ET-1/ETAR signaling is involved
in ventral identiﬁcation of the pharyngeal arches through Gq/11-
mediated, Dlx5/6-dependet mechanisms. These ﬁndings indicate that
the ET-1/ETAR signaling pathway is involved in craniofacial and cardiac
development through different trimeric G-proteins.
doi:10.1016/j.lfs.2013.12.218
Erythropoietin induced blood pressure rise, vascular inﬂammation
and oxidative stress in mice overexpressing human endothelin-1:
Improvement by exercise
Pierre Paradisa, Tlili Barhoumia,d, Marie Brieta,b,e, Daniel A. Kasala,c,
Pascal Laurantd, Ernesto L. Schiffrina,b
aLady Davis Institute for Medical Research, McGill University, Montreal,
PQ, Canada
bDepartment of Medicine, Sir Mortimer B. Davis-Jewish General Hospital,
McGill University, Montreal, PQ, Canada
cState University of Rio de Janeiro, Brazil
dUniversite d'Avignon et des Pays de Vaucluse, Avignon, France
eDepartment of Pharmacology, Institut National de la Sante et de la
Recherche Medicale, U970-PARCC, Hopital Europeen Georges Pompidou,
Assistance Publique-Hopitaux de Paris, Paris, France
E-mail address: pierre.paradis@mcgill.ca (P. Paradis)
Erythropoietin (EPO) is used to correct anemia in chronic kidney
disease (CKD). EPO has been shown to increase blood pressure (BP) in
patients and animals with CKD. Plasma endothelin (ET)-1 levels are
increased in CKD animals and patients, and enhanced by EPO. EPO-
induced BP rise was blunted by ETA receptor blockers. This study was
designed to determine whether pre-existing ET-1 overexpression is
required for EPO to cause adverse vascular effects, and whether this
could be prevented by exercise training. We treated 8–10-week old
male mice with endothelial speciﬁc ET-1 overexpression (eET-1) with
EPO (100 IU/kg, SC, 3 times/week) or not, and subjected or not the
mice to swimming exercise training (1 h/d, 6 d/week) for 8 weeks.Wild-
type littermate mice were treated or not with EPO as above and
maintained sedentary. EPO increased systolic BP by 24 mmHg (P b 0.05)
in eET-1 mice, and decreased vasodilatory responses to acetylcholine by
25% (P b 0.01). EPO enhanced ET-1-induced increase in resistance artery
media/lumen by 31% (P b 0.05), aortic NADPH oxidase activity by 50%
0024-3205/© 2013 The Authors. Published by Elsevier Inc.
Life Sciences 93 (2013) e29–e31
Contents lists available at ScienceDirect
Life Sciences
j ourna l homepage: www.e lsev ie r.com/ locate / l i fesc ie
 CC BY-NC-ND license.Open access under
